Insider Title Company Date Price Return Shares Value
Brawley Otis W Non-Executive Director Lyell Immunopharma, Inc. (LYEL) 2025-03-31 $0.56 0.0% 35,640 $19,958
Return Profit / (loss) Cost
Total 0.0% $0 $19,958